Evidence map›Paper›PMID 31696443›Full record

ArticleEcotoxicology (London, England)2019

Effect of azadirachtin on mortality and immune response of leaf-cutting ants.

Karina D Amaral, Lailla C Gandra, Marco Antonio de Oliveira, Danival J de Souza, Terezinha M C Della Lucia

Abstract read
PubMed Publisher
In one paragraph

Article in Ecotoxicology (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karina D AmaralDepartamento de Entomologia, Universidade Federal de Viçosa, Viçosa, MG, 36570-900, Brazil. karina_damaral@yahoo.com.br.ORCID http://orcid.org/0000-0002-3371-0696
Lailla C GandraDepartamento de Entomologia, Universidade Federal de Viçosa, Viçosa, MG, 36570-900, Brazil.
Marco Antonio de OliveiraUniversidade Federal de Viçosa, Florestal, MG, 35690-000, Brazil.
Danival J de SouzaUniversidade Federal do Tocantins, Gurupi, TO, 77402-970, Brazil.
Terezinha M C Della LuciaDepartamento de Biologia Animal, Universidade Federal de Viçosa, Viçosa, MG, 36570-900, Brazil.
Universidade Federal de Viçosa · BRUniversidade Federal do Tocantins · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leaf-cutting ants are difficult pests to control because they have numerous defense strategies and are highly selective in their plant harvesting choices. The search for effective pest control methods that have minimal negative effects on the environment has been continuous. Azadirachtin, a compound extracted from the neem tree (Azadirachta indica), is a promising alternative for the control of various pests, as it is toxic to some insects but readily degrades in the environment. In this study, we evaluated the effects of azadirachtin on the mortality, through topical exposure to the compound, and immune response, by introducing an artificial antigen into leaf-cutting ants Atta sexdens and Acromyrmex subterraneus subterraneus. Azadirachtin caused death to minor and major workers of both species in a concentration-dependent manner. Topical application of the compound did not diminish the immune response of ants in a microfilament encapsulation assay. Azadirachtin showed no effect on the immune response of workers but increased worker mortality, which indicates its potential as an ant control agent.

Indexed as

AntsInsect ControlInsecticidesLimoninsAnimalsImmunity, InnateLongevityazadirachtinInsecticidesLimoninsAttiniEncapsulationFormicidaeHymenopteraImmunityNeem

Identifiers

PMID31696443
OpenAlexW2988913890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.